The DOI matches its Crossref record; 345 of the 345 references it cites were found in a registry or an index.
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Open accessAbstract
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells. P2X7 activation results in a number of downstream events, including the release of proinflammatory mediators and cell death and proliferation. As such, P2X7 plays important roles in various inflammatory, immune, neurologic and musculoskeletal disorders. This review focuses on the use of P2X7 antagonists in rodent models of neurologic disease and injury, inflammation, and musculoskeletal and other disorders. The cloning and characterization of human, rat, mouse, guinea pig, dog, and Rhesus macaque P2X7, as well as recent observations regarding the gating and permeability of P2X7, are discussed. Furthermore, this review discusses polymorphic and splice variants of P2X7, as well as the generation and use of P2X7 knockout mice. Recent evidence for emerging signaling pathways downstream of P2X7 activation and the growing list of negative and positive modulators of P2X7 activation and expression are also described. In addition, the use of P2X7 antagonists in numerous rodent models of disease is extensively summarized. Finally, the use of P2X7 antagonists in clinical trials in humans and future directions exploring P2X7 as a therapeutic target are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,147
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Yegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
Purine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
Burnstock, G., & Knight, G. E. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)40002-3 · Cited by 795
A general protocol for the generation of Nanobodies for structural biology
Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkönig, A., Ruf, A., Muyldermans, S., Hol, W. G. J., Kobilka, B. K., & Steyaert, J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.039 · Cited by 790
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789
The inflammasome: an integrated view
Gross, O., Thomas, C. J., Guarda, G., & Tschopp, J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01046.x · Cited by 778
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 738
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 611
P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels
Nicke, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3016 · Cited by 554
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 551
P2X7Receptors Mediate ATP Release and Amplification of Astrocytic Intercellular Ca2+Signaling
Suadicani, S. O., Brosnan, C. F., & Scemes, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3902-05.2006 · Cited by 512
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
P2X7 receptor inhibition improves recovery after spinal cord injury
Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 494
Activation and Regulation of Purinergic P2X Receptor Channels
Coddou, C., Yan, Z., Obsil, T., Huidobro-Toro, J. P., & Stojilkovic, S. S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003129 · Cited by 493
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., & Gabel, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6436 · Cited by 490
P2X 7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes
Duan, S., Anderson, C. M., Keung, E. C., Chen, Y., Chen, Y., & Swanson, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01320.2003 · Cited by 489
The Permeabilizing ATP Receptor, P2X7
Rassendren, F., Buell, G. N., Virginio, C., Collo, G., North, R. A., & Surprenant, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5482 · Cited by 478
Pore architecture and ion sites in acid-sensing ion channels and P2X receptors
Gonzales, E. B., Kawate, T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08218 · Cited by 455
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435
Suramin: a reversible P2‐purinoceptor antagonist in the mouse vas deferens
Dunn, P. M., & Blakeley, A. G. H. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11427.x · Cited by 426
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L., Blum, L., Takano, T., Tian, G.-F., Goldman, S. A., & Nedergaard, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902531106 · Cited by 424
Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 414
Pore dilation of neuronal P2X receptor channels
Virginio, C., MacKenzie, A., Rassendren, F. A., North, R. A., & Surprenant, A. (1999) · Nature Neuroscience · doi:10.1038/7225 · Cited by 413
P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrin, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 410
Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., & Rubartelli, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308558101 · Cited by 409
Matute, C., Torre, I., Pérez-Cerdá, F., Pérez-Samartín, A., Alberdi, E., Etxebarria, E., Arranz, A. M., Ravid, R., Rodríguez-Antigüedad, A., Sánchez-Gómez, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0579-07.2007 · Cited by 405
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L.-H., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Riteau, N., Gasse, P., Fauconnier, L., Gombault, A., Couegnat, M., Fick, L., Kanellopoulos, J., Quesniaux, V. F. J., Marchand-Adam, S., Crestani, B., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0359oc · Cited by 397
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Compan, V., Baroja-Mazo, A., López-Castejón, G., Gomez, A. I., Martínez, C. M., Angosto, D., Montero, M. T., Herranz, A. S., Bazán, E., Reimers, D., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.013 · Cited by 392
The P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374
P2X7 receptors in the nervous system
SPERLAGH, B., VIZI, E., WIRKNER, K., & ILLES, P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.007 · Cited by 373
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., & Di Virgilio, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53082-9 · Cited by 367
Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus
Thompson, R. J., Jackson, M. F., Olah, M. E., Rungta, R. L., Hines, D. J., Beazely, M. A., MacDonald, J. F., & MacVicar, B. A. (2008) · Science · doi:10.1126/science.1165209 · Cited by 365
Pannexin-1 Is Required for ATP Release during Apoptosis but Not for Inflammasome Activation
Qu, Y., Misaghi, S., Newton, K., Gilmour, L. L., Louie, S., Cupp, J. E., Dubyak, G. R., Hackos, D., & Dixit, V. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100478 · Cited by 363
Sorge, R. E., Trang, T., Dorfman, R., Smith, S. B., Beggs, S., Ritchie, J., Austin, J.-S., Zaykin, D. V., Meulen, H. V., Costigan, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2710 · Cited by 359
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Adinolfi, E., Raffaghello, L., Giuliani, A. L., Cavazzini, L., Capece, M., Chiozzi, P., Bianchi, G., Kroemer, G., Pistoia, V., & Di Virgilio, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1947 · Cited by 347
Seman, M., Adriouch, S., Scheuplein, F., Krebs, C., Freese, D., Glowacki, G., Deterre, P., Haag, F., & Koch-Nolte, F. (2003) · Immunity · doi:10.1016/s1074-7613(03)00266-8 · Cited by 335
Pharmacological characterization of recombinant human and rat P2X receptor subtypes
Bianchi, B. R., Lynch, K. J., Touma, E., Niforatos, W., Burgard, E. C., Alexander, K. M., Park, H. S., Yu, H., Metzger, R., Kowaluk, E., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00350-7 · Cited by 331
TRPV1 shows dynamic ionic selectivity during agonist stimulation
Chung, M.-K., Güler, A. D., & Caterina, M. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2102 · Cited by 327
Evans, R. J., Lewis, C., Buell, G., Valera, S., North, R. A., & Surprenant, A. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10232-0 · Cited by 316
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor
Gu, B. J., Zhang, W., Worthington, R. A., Sluyter, R., Dao-Ung, P., Petrou, S., Barden, J. A., & Wiley, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010353200 · Cited by 313
Self-citationGever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., & Ford, A. P. D. W. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0070-9 · Cited by 298
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses
Lambrecht, G., Friebe, T., Grimm, U., Windscheif, U., Bungardt, E., Hildebrandt, C., Bäumert, H. G., Spatz-Kümbel, G., & Mutschler, E. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90877-7 · Cited by 297
A Novel Recombinant Plasma Membrane-targeted Luciferase Reveals a New Pathway for ATP Secretion
Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., & Di Virgilio, F. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0222 · Cited by 297
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293
Mitochondria: Sovereign of inflammation?
Tschopp, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141436 · Cited by 292
TLR9 and the NLRP3 Inflammasome Link Acinar Cell Death With Inflammation in Acute Pancreatitis
Hoque, R., Sohail, M., Malik, A., Sarwar, S., Luo, Y., Shah, A., Barrat, F., Flavell, R., Gorelick, F., Husain, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.041 · Cited by 292
Clark, A. K., Staniland, A. A., Marchand, F., Kaan, T. K. Y., McMahon, S. B., & Malcangio, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3295-09.2010 · Cited by 291
Bacterial protein toxins that modify host regulatory GTPases
Aktories, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2592 · Cited by 288
Autocrine regulation of T‐cell activation by ATP release and P2X 7 receptors
Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P. A., & Junger, W. G. (2009) · The FASEB Journal · doi:10.1096/fj.08-126458 · Cited by 286
Ferrari, D., Wesselborg, S., Bauer, M. K. A., & Schulze-Osthoff, K. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1635 · Cited by 286
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286
Ke, H. Z., Qi, H., Weidema, A. F., Zhang, Q., Panupinthu, N., Crawford, D. T., Grasser, W. A., Paralkar, V. M., Li, M., Audoly, L. P., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0021 · Cited by 283
Ferrari, D., Los, M., Bauer, M. K. A., Vandenabeele, P., Wesselborg, S., & Schulze-Osthoff, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00270-7 · Cited by 276
Adinolfi, E., Callegari, M. G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M. R., Pinton, P., Rizzuto, R., & Di Virgilio, F. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1025 · Cited by 275
A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP
Qiu, F., & Dahl, G. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00433.2008 · Cited by 275
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271
Donnelly‐Roberts, D. L., & Jarvis, M. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707265 · Cited by 266
Reanalysis of P2X7Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264
Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagné, B., Labbé, M., Binder, E. B., Uhr, M., Paez-Pereda, M., Sillaber, I., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl166 · Cited by 261
P2X7 Receptors: Channels, Pores and More
Volonte, C., Apolloni, S., D. Skaper, S., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 254
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandonà, D., Markwardt, F., Schmalzing, G., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-153601 · Cited by 254
STOCK, T. C., BLOOM, B. J., WEI, N., ISHAQ, S., PARK, W., WANG, X., GUPTA, P., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 243
Panenka, W., Jijon, H., Herx, L. M., Armstrong, J. N., Feighan, D., Wei, T., Yong, V. W., Ransohoff, R. M., & MacVicar, B. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07135.2001 · Cited by 233
Nelson, D. W., Gregg, R. J., Kort, M. E., Perez-Medrano, A., Voight, E. A., Wang, Y., Grayson, G., Namovic, M. T., Donnelly-Roberts, D. L., Niforatos, W., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051202e · Cited by 233
Basso, A. M., Bratcher, N. A., Harris, R. R., Jarvis, M. F., Decker, M. W., & Rueter, L. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.018 · Cited by 224
Díaz-Hernández, M., Díez-Zaera, M., Sánchez-Nogueiro, J., Gómez-Villafuertes, R., Canals, J. M., Alberch, J., Miras-Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 224
P2X7-related modulation of pathological nociception in rats
McGaraughty, S., Chu, K. L., Namovic, M. T., Donnelly-Roberts, D. L., Harris, R. R., Zhang, X.-F., Shieh, C.-C., Wismer, C. T., Zhu, C. Z., Gauvin, D. M., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.035 · Cited by 220
Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor
Baricordi, O. R., Melchiorri, L., Adinolfi, E., Falzoni, S., Chiozzi, P., Buell, G., & Di Virgilio, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33206 · Cited by 212
Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Weber, F. C., Esser, P. R., Müller, T., Ganesan, J., Pellegatti, P., Simon, M. M., Zeiser, R., Idzko, M., Jakob, T., & Martin, S. F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092489 · Cited by 207
Identification and characterization of splice variants of the human P2X7 ATP channel
Cheewatrakoolpong, B., Gilchrest, H., Anthes, J. C., & Greenfeder, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.087 · Cited by 207
He, Y., Franchi, L., & Núñez, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202737 · Cited by 206
Gu, B. J., Zhang, W. Y., Bendall, L. J., Chessell, I. P., Buell, G. N., & Wiley, J. S. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.4.c1189 · Cited by 204
A Polymorphism in the P2X 7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis
Fernando, S. L., Saunders, B. M., Sluyter, R., Skarratt, K. K., Goldberg, H., Marks, G. B., Wiley, J. S., & Britton, W. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-970oc · Cited by 203
Self-citationBarden, N., Harvey, M., Gagné, B., Shink, E., Tremblay, M., Raymond, C., Labbé, M., Villeneuve, A., Rochette, D., Bordeleau, L., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30303 · Cited by 202
Garbers, C., Jänner, N., Chalaris, A., Moss, M. L., Floss, D. M., Meyer, D., Koch-Nolte, F., Rose-John, S., & Scheller, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229393 · Cited by 201
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Diaz-Hernandez, J. I., Gomez-Villafuertes, R., León-Otegui, M., Hontecillas-Prieto, L., del Puerto, A., Trejo, J. L., Lucas, J. J., Garrido, J. J., Gualix, J., Miras-Portugal, M. T., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.040 · Cited by 201
Blockade of Human P2X7 Receptor Function With a Monoclonal Antibody
Buell, G., Chessell, I. P., Michel, A. D., Collo, G., Salazzo, M., Herren, S., Gretener, D., Grahames, C., Kaur, R., Kosco-Vilbois, M. H., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3521 · Cited by 201
Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L., Fraser, I., Nepomuceno, D., Neff, R. A., Welty, N., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12314 · Cited by 199
The human P2X7 receptor and its role in innate immunity
Wiley, J. S., Sluyter, R., Gu, B. J., Stokes, L., & Fuller, S. J. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01780.x · Cited by 198
Self-citationExtracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line.
Steinberg, T. H., & Silverstein, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61477-2 · Cited by 196
Adriouch, S., Dox, C., Welge, V., Seman, M., Koch-Nolte, F., & Haag, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4108 · Cited by 196
Engel, T., Gomez‐Villafuertes, R., Tanaka, K., Mesuret, G., Sanz‐Rodriguez, A., Garcia‐Huerta, P., Miras‐Portugal, M. T., Henshall, D. C., & Diaz‐Hernandez, M. (2012) · The FASEB Journal · doi:10.1096/fj.11-196089 · Cited by 194
Zhao, J., Wang, H., Dai, C., Wang, H., Zhang, H., Huang, Y., Wang, S., Gaskin, F., Yang, N., & Man Fu, S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38174 · Cited by 192
The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes
Gargett, C. E., & Wiley, J. S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701081 · Cited by 190
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
Baricordi, O., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., & Di Virgilio, F. (1996) · Blood · doi:10.1182/blood.v87.2.682.bloodjournal872682 · Cited by 187
Nicke, A., Kuan, Y.-H., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D. C., Murrell-Lagnado, R. D., & Soto, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033134 · Cited by 187
Arbeloa, J., Pérez-Samartín, A., Gottlieb, M., & Matute, C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.014 · Cited by 187
Budai, M. M., Varga, A., Milesz, S., Tőzsér, J., & Benkő, S. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.005 · Cited by 179
Kim, J.-E., & Kang, T.-C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44818 · Cited by 179
Gu, B., Bendall, L. J., & Wiley, J. S. (1998) · Blood · doi:10.1182/blood.v92.3.946 · Cited by 174
Avshalumov, M. V., & Rice, M. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834314100 · Cited by 173
Choi, H. B., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5417-06.2007 · Cited by 173
Stokes, L., Fuller, S. J., Sluyter, R., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2010) · The FASEB Journal · doi:10.1096/fj.09-150862 · Cited by 173
Self-citationShemon, A. N., Sluyter, R., Fernando, S. L., Clarke, A. L., Dao-Ung, L.-P., Skarratt, K. K., Saunders, B. M., Tan, K. S., Gu, B. J., Fuller, S. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507816200 · Cited by 172
Self-citationAntipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model
Naviaux, R. K., Zolkipli, Z., Wang, L., Nakayama, T., Naviaux, J. C., Le, T. P., Schuchbauer, M. A., Rogac, M., Tang, Q., Dugan, L. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057380 · Cited by 171
Smart, M. L., Gu, B., Panchal, R. G., Wiley, J., Cromer, B., Williams, D. A., & Petrou, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211094200 · Cited by 170
An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor
Wiley, J. S., Dao-Ung, L.-P., Li, C., Shemon, A. N., Gu, B. J., Smart, M. L., Fuller, S. J., Barden, J. A., Petrou, S., & Sluyter, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212759200 · Cited by 166
Self-citationP2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Sharp, A. J., Polak, P. E., Simonini, V., Lin, S. X., Richardson, J. C., Bongarzone, E. R., & Feinstein, D. L. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-33 · Cited by 166
Purinergic Receptors Mediate Two Distinct Glutamate Release Pathways in Hippocampal Astrocytes
Fellin, T., Pozzan, T., & Carmignoto, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510679200 · Cited by 165
Feng, Y., Li, X., Wang, L., Zhou, L., & Gorodeski, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602999200 · Cited by 164
The P2X7 Receptor Channel Pore Dilates under Physiological Ion Conditions
Yan, Z., Li, S., Liang, Z., Tomić, M., & Stojilkovic, S. S. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200810059 · Cited by 164
Cabrini, G., Falzoni, S., Forchap, S. L., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O. R., & Di Virgilio, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.82 · Cited by 163
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Di Virgilio, F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 161
P2X7 Receptor Channels Allow Direct Permeation of Nanometer-Sized Dyes
Browne, L. E., Compan, V., Bragg, L., & North, R. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2235-12.2013 · Cited by 160
Kerur, N., Hirano, Y., Tarallo, V., Fowler, B. J., Bastos-Carvalho, A., Yasuma, T., Yasuma, R., Kim, Y., Hinton, D. R., Kirschning, C. J., et al. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12500 · Cited by 158
Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor
Gu, B. J., & Wiley, J. S. (2006) · Blood · doi:10.1182/blood-2005-07-2994 · Cited by 158
Zanovello, P., Bronte, V, Rosato, A., Pizzo, P., & Di Virgilio, F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1545 · Cited by 158
Chu, K., Yin, B., Wang, J., Peng, G., Liang, H., Xu, Z., Du, Y., Fang, M., Xia, Q., & Luo, B. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-69 · Cited by 157
Marques-da-Silva, C., Chaves, M. M., Castro, N. G., Coutinho‐Silva, R., & Guimaraes, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01254.x · Cited by 154
A Potential Role for P2X7R in Allergic Airway Inflammation in Mice and Humans
Müller, T., Vieira, R. P., Grimm, M., Dürk, T., Cicko, S., Zeiser, R., Jakob, T., Martin, S. F., Blumenthal, B., Sorichter, S., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0129oc · Cited by 153
El-Moatassim, C., & Dubyak, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35890-3 · Cited by 153
Humphreys, B. D., & Dubyak, G. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.2.265 · Cited by 151
Cockcroft, S., & Gomperts, B. D. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp013002 · Cited by 150
Cloning and functional characterisation of the mouse P2X7 receptor
Chessell, I. P., Simon, J., Hibell, A. D., Michel, A. D., Barnard, E. A., & Humphrey, P. P. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01332-5 · Cited by 149
A role for P2X 7 in microglial proliferation
Bianco, F., Ceruti, S., Colombo, A. V., Fumagalli, M., Ferrari, D., Pizzirani, C., Matteoli, M., Virgilio, F. D., Abbracchio, M. P., & Verderio, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04101.x · Cited by 148
Jimenez‐Pacheco, A., Mesuret, G., Sanz‐Rodriguez, A., Tanaka, K., Mooney, C. M., Conroy, R. M., Miras‐Portugal, M. T., Dı́az-Hernández, M., Henshall, D. C., & Engel, T. (2013) · Epilepsia · doi:10.1111/epi.12257 · Cited by 148
P2X7 Receptor Signaling in the Pathogenesis of Smoke-Induced Lung Inflammation and Emphysema
Lucattelli, M., Cicko, S., Müller, T., Lommatzsch, M., Cunto, G. D., Cardini, S., Sundas, W., Grimm, M., Zeiser, R., Dürk, T., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0038oc · Cited by 148
Scheuplein, F., Schwarz, N., Adriouch, S., Krebs, C. F., Bannas, P., Rissiek, B., Séman, M., Haag, F., & Koch‐Nolte, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801711 · Cited by 147
Gu, B. J., Sluyter, R., Skarratt, K. K., Shemon, A. N., Dao‐Ung, L., Fuller, S. J., Barden, J. A., Clarke, A. L., Petrou, S., & Wiley, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313902200 · Cited by 147
Self-citationSignificance of P2X7 Receptor Variants to Human Health and Disease
Sluyter, R., & Stokes, L. (2011) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221511794839219 · Cited by 147
Self-citationPurines and their roles in apoptosis
Chow, S. C., Kass, G. E. N., & Orrenius, S. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00123-8 · Cited by 146
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 146
Melani, A., Amadio, S., Gianfriddo, M., Vannucchi, M. G., Volonté, C., Bernardi, G., Pedata, F., & Sancesario, G. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600250 · Cited by 145
Extracellular Nucleotides Act Through P2X7 Receptors to Activate NF-κB in Osteoclasts
Korčok, J., Raimundo, L., Ke, H. Z., Sims, S. M., & Dixon, S. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040108 · Cited by 144
P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P. (2012) · The FASEB Journal · doi:10.1096/fj.12-205765 · Cited by 142
Roger, S., Mei, Z.-Z., Baldwin, J. M., Dong, L., Bradley, H., Baldwin, S. A., Surprenant, A., & Jiang, L. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.005 · Cited by 142
The Role of the P2X7 Receptor in Infectious Diseases
Miller, C., Boulter, N. R., Fuller, S. J., Zakrzewski, A. M., Lees, M. P., Saunders, B. M., Wiley, J. S., & Smith, N. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002212 · Cited by 141
Qu, Y., & Dubyak, G. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9132-8 · Cited by 141
Chen, L., & Brosnan, C. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3115 · Cited by 139
Characterization of a selective and potent antagonist of human P2X7receptors, AZ11645373
Stokes, L., Jiang, L., Alcaraz, L., Bent, J., Bowers, K., Fagura, M., Furber, M., Mortimore, M., Lawson, M., Theaker, J., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706933 · Cited by 138
Self-citationHoque, R., Sohail, M. A., Salhanick, S. D., Malik, A. F., Ghani, A., Robson, S. C., & Mehal, W. Z. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00352.2011 · Cited by 138
Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?
Sesti, F., Liu, S., & Cai, S. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.09.008 · Cited by 138
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH
Chen, S., Ma, Q., Krafft, P. R., Hu, Q., Rolland, W. B., Sherchan, P., Zhang, J., Tang, J., & Zhang, J. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.011 · Cited by 136
Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease
Ryu, J. K., & McLarnon, J. G. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3283179333 · Cited by 134
Roger, S., Pelegrín, P., & Surprenant, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0696-08.2008 · Cited by 133
Amino Acid Residues in the P2X7 Receptor that Mediate Differential Sensitivity to ATP and BzATP
Young, M. T., Pelegrín, P., & Surprenant, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030163 · Cited by 132
Apolloni, S., Parisi, C., Pesaresi, M. G., Rossi, S., Carrì, M. T., Cozzolino, M., Volonté, C., & D’Ambrosi, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203262 · Cited by 132
López‐Castejón, G., Theaker, J., Pelegrín, P., Clifton, A. D., Braddock, M., & Surprenant, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000436 · Cited by 130
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128
P2X7 Deficiency Attenuates Renal Injury in Experimental Glomerulonephritis
Taylor, S. R. J., Turner, C. M., Elliott, J. I., McDaid, J., Hewitt, R., Smith, J., Pickering, M. C., Whitehouse, D. L., Cook, H. T., Burnstock, G., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060559 · Cited by 127
Homotrimeric complexes are the dominant assembly state of native P2X7 subunits
Nicke, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.042 · Cited by 124
Eltom, S. M., Stevenson, C. S., Rastrick, J. M. D., Dale, N., Raemdonck, K., Wong, S., Catley, M. C., Belvisi, M. G., & Birrell, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024097 · Cited by 124
Koch‐Nolte, F., Reyelt, J., Schößow, B., Schwarz, N., Scheuplein, F., Rothenburg, S., Haag, F., Alzogaray, V., Cauerhff, A., & Goldbaum, F. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8661com · Cited by 123
Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X., Marschall, V., Brutkowski, W., Mooney, E. R., Górecki, D. C., & Murrell‐Lagnado, R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01624.x · Cited by 122
Role of P2X 7 Receptors in Ischemic and Excitotoxic Brain Injury In Vivo
Feuvre, R. A. L., Brough, D., Touzani, O., & Rothwell, N. J. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048519.34839.97 · Cited by 122
Buchanan, M. S., Carroll, A. R., Addepalli, R., Avery, V. M., Hooper, J. N. A., & Quinn, R. J. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo062007q · Cited by 122
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms
Beigi, R. D., Kertesy, S. B., Aquilina, G. R., & Dubyak, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705470 · Cited by 121
Chu, Y., Zhang, Y., Zhang, Y., & Zhao, Z.-Q. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.001 · Cited by 119
Delarasse, C., Auger, R., Gonnord, P., Fontaine, B., & Kanellopoulos, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200618 · Cited by 118
P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
Takenouchi, T., Sekiyama, K., Sekigawa, A., Fujita, M., Waragai, M., Sugama, S., Iwamaru, Y., Kitani, H., & Hashimoto, M. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0069-y · Cited by 118
Donnelly‐Roberts, D. L., Namovic, M. T., Faltynek, C. R., & Jarvis, M. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059600 · Cited by 118
Are second messengers crucial for opening the pore associated with P2X7 receptor?
Faria, R. X., DeFarias, F. P., & Alves, L. A. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00215.2004 · Cited by 118
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Zhong, C., Wade, C. L., Chandran, P., Zhu, C., Carroll, W. A., Perez‐Medrano, A., Iwakura, Y., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.018 · Cited by 117
The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels
Brandao‐Burch, A., Key, M. L., Patel, J. J., Arnett, T. R., & Orriss, I. R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00041 · Cited by 117
Jiang, L., Baldwin, J. M., Roger, S., & Baldwin, S. A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00055 · Cited by 117
Wilson, H. L., Francis, S., Dower, S., & Crossman, D. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1202 · Cited by 116
Gating the pore of P2X receptor channels
Li, M., Chang, T.-H., Silberberg, S. D., & Swartz, K. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2151 · Cited by 116
Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
Nörenberg, W., Sobottka, H., Hempel, C., Plötz, T., Fischer, W., Schmalzing, G., & Schaefer, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01987.x · Cited by 116
Gu, B. J., Saunders, B. M., Jursik, C., & Wiley, J. S. (2009) · Blood · doi:10.1182/blood-2009-11-251744 · Cited by 114
Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7
Vergani, A., Tezza, S., D’Addio, F., Fotino, C., Liu, K., Niewczas, M. A., Bassi, R., Molano, R. D., Kleffel, S., Petrelli, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.123653 · Cited by 113
Mingam, R., Smedt, V. D., Amédée, T., Bluthé, R.-M., Kelley, K. W., Dantzer, R., & Layé, S. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.007 · Cited by 111
Chaumont‐Dubel, S., & Khakh, B. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803008105 · Cited by 110
Buttini, M., Mir, A. K., Appel, K., Wiederhold, K.-H., Limonta, S., Gebicke‐Haerter, P. J., & Boddeke, H. W. G. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701502 · Cited by 110
He, W., Cui, J. G., Du, L., Zhao, Y., Burnstock, G., Zhou, H., & Ruan, H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.015 · Cited by 109
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108
DellʼAntonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., & Ferrero, M. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10678 · Cited by 108
Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo
Hu, H., Lu, W., Zhang, M., et al. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.06.017 · Cited by 107
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation
Banke, T. G., Chaplan, S. R., & Wickenden, A. D. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00489.2009 · Cited by 106
Evidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosis
Jamieson, S., Rangel, A. L. P., Hargrave, A. C., de Roubaix, L.-A., Mui, E. J., Boulter, N. R., Miller, E. N., Fuller, S. J., Wiley, J. S., Castellucci, L. C., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.31 · Cited by 105
γ-Irradiation induces P2X7 receptor-dependent ATP release from B16 melanoma cells
Ohshima, Y., Tsukimoto, M., Takenouchi, T., et al. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.008 · Cited by 104
Bartlett, R., Yerbury, J. J., & Sluyter, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/271813 · Cited by 103
Self-citationP2X7 Is a Scavenger Receptor for Apoptotic Cells in the Absence of Its Ligand, Extracellular ATP
Gu, B. J., Saunders, B. M., Petrou, S., & Wiley, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101178 · Cited by 99
P2 Receptors in Bone-Modulation of Osteoclast Formation and Activity via P2X7 Activation
Gartland, A., Buckley, K. M., Hipskind, R. A., et al. (2003) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v13.i24.150 · Cited by 98
Marcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97
Notomi, S., Hisatomi, T., Murakami, Y., Terasaki, H., Sonoda, S., Asato, R., Takeda, A., Ikeda, Y., Enaida, H., Sakamoto, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053338 · Cited by 97
Andó, R., Méhész, B., Gyires, K., Illés, P., & Sperlágh, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00596.x · Cited by 96
Gu, B. J., Rathsam, C., Stokes, L., McGeachie, A. B., & Wiley, J. S. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00079.2009 · Cited by 96
Self-citationThe Antibiotic Polymyxin B Modulates P2X7 Receptor Function
Ferrari, D., Pizzirani, C., Adinolfi, E., Forchap, S., Sitta, B., Turchet, L., Falzoni, S., Minelli, M., Baricordi, R., & Virgilio, F. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4652 · Cited by 95
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration
Pellegatti, P., Falzoni, S., Donvito, G., Lemaire, I. B., & Virgilio, F. D. (2011) · The FASEB Journal · doi:10.1096/fj.10-169854 · Cited by 94
Neuron‐specific distribution of P2X7 purinergic receptors in the monkey retina
Ishii, K., Kaneda, M., Li, H., Rockland, K. S., & Hashikawa, T. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10608 · Cited by 92
Glas, R., Sauter, N. S., Schulthess, F. T., Shu, L., Oberholzer, J., & Maedler, K. (2009) · Diabetologia · doi:10.1007/s00125-009-1349-0 · Cited by 92
Acuña‐Castillo, C., Coddou, C., Bull, P., Brito-Echeverría, J., & Huidobro-Toro, J. P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04343.x · Cited by 90
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Hansen, R. R., Nielsen, C. K., Nasser, A., Thomsen, S. I. M., Eghorn, L. F., Pham, Y., Schulenburg, C., Syberg, S., Ding, M. L., Stojilković, S. S., et al. (2011) · Pain · doi:10.1016/j.pain.2011.03.024 · Cited by 90
Stunff, H. L., Auger, R., Kanellopoulos, J., & Raymond, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313064200 · Cited by 90
The P2X7receptor as a therapeutic target
Romagnoli, R., Baraldi, P. G., Cruz‐López, O., Lopez-Cara, L. C., Preti, D., Borea, P. A., & Gessi, S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.647 · Cited by 89
P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties
Compan, V., Ulmann, L., Stelmashenko, O., Chemin, J., Chaumont‐Dubel, S., & Rassendren, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6332-11.2012 · Cited by 89
Is pannexin the pore associated with the P2X7 receptor?
Alberto, A. V. P., Faria, R. X., Couto, C. G. C., Ferreira, L. G. B., Souza, C. A. M., Teixeira, P. C. N., Fróes, M. M., & Alves, L. A. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0868-x · Cited by 88
Puthussery, T., & Fletcher, E. L. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.21964 · Cited by 88
Moore, S., & Mackenzie, A. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900394 · Cited by 87
Cited by
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Ion Channels in Innate and Adaptive Immunity
Feske, S., Wulff, H., & Skolnik, E. Y. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112212 · Cited by 768
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 596
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
Metadata
- Authors
- Bartlett, R., Stokes, L., & Sluyter, R.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 66
- Issue
- 3
- Pages
- 638-675
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2128767149
- Cited by
- 393
- References
- 345
- FWCI
- 28.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.